aap Implantate AG (LTS:0N5A) Operating Cash Flow per Share : €-0.28 (TTM As of Jun. 2024)

View and export this data going back to 2010. Start your Free Trial

What is aap Implantate AG Operating Cash Flow per Share?

aap Implantate AG's operating cash flow per share for the six months ended in Jun. 2024 was €-0.10. aap Implantate AG's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.28.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 30.10% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 33.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for aap Implantate AG's Operating Cash Flow per Share or its related term are showing as below:

LTS:0N5A' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -46 Med: 10.2 Max: 73.4
Current: 30.1

During the past 13 years, aap Implantate AG's highest 3-Year average Operating Cash Flow per Share Growth Rate was 73.40% per year. The lowest was -46.00% per year. And the median was 10.20% per year.

LTS:0N5A's 3-Year OCF Growth Rate is ranked better than
77.16% of 696 companies
in the Medical Devices & Instruments industry
Industry Median: 8.25 vs LTS:0N5A: 30.10

aap Implantate AG Operating Cash Flow per Share Historical Data

The historical data trend for aap Implantate AG's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

aap Implantate AG Operating Cash Flow per Share Chart

aap Implantate AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-1.80

-1.06

-0.50

-0.32

-0.36

aap Implantate AG Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.22	-0.10	-0.17	-0.18	-0.10

Competitive Comparison of aap Implantate AG's Operating Cash Flow per Share

For the Medical Devices subindustry, aap Implantate AG's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

aap Implantate AG's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, aap Implantate AG's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where aap Implantate AG's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

aap Implantate AG Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

aap Implantate AG's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-2.992	/	8.295
	=	-0.36

aap Implantate AG's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Jun. 2024 )	=	Cash Flow from Operations (Q: Jun. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Jun. 2024 )
	=	-1.021	/	9.863
	=	-0.10

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.28

aap Implantate AG Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of aap Implantate AG's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

aap Implantate AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » aap Implantate AG (LTS:0N5A) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

AAQ1:Germany

Address

Lorenzweg 5, Berlin, DEU, 12099

Website

https://www.aap.de

aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. The company classifies its products that are Trauma and Others. The product line of the company consists of a plating system under the brand LOQTEQ, and cannulated screws. The company's projects such as antibacterial silver coating technology and magnesium-based implants. It develops a plating system for the Shoulder, Knee, Elbow, Wrist, and Ankle Joint. The company sells its product directly to hospitals, syndicates, and hospital groups with the help of distributors.

aap Implantate AG Headlines

No Headlines